Processing....
Hello, Guest!
Executive Mosaic
POC
Executive Biz
Executive Gov
GovConExec
Submit your news
Friday, April 26, 2024
GovCon Wire
Your Direct Source for Government Contracting News
Home
Executives
GovCon Experts
GovCon Executives
Executive Spotlights
Contract Awards
Executive Moves
M&A Activity
Technology
Videos
Events
More
Articles
Contribute to GCW
2022 Events
Articles & Insights
Wash100
Press Releases
Weekly Roundup
Advertise
Jobs
Tag:
cancer immunotherapy
Home
cancer immunotherapy
Press Releases
Leidos Earns US Patent for Peptide-Based Treatment for Cancer, Infectious Diseases
TYSONS CORNER, VA, January 8, 2018 â The Leidos (NYSE: LDOS) life sciences business unit has been awarded a patent for peptide-based
Executive Mosaic
POC
Executive Biz
Executive Gov
GovConExec
Get unlimited access today. Continue reading with one of the options below
Login Here
To enjoy unlimited access to articles, interviews, and invaluable govcon content. You’ll also receive our daily briefing straight to your inbox.
Submit
By submitting my information, I agree to the
Privacy Policy
and Terms of Service.